Business Wire

FourKites Appoints New President Rocky Subramanian to Accelerate Global Expansion

6.4.2023 11:08:00 EEST | Business Wire | Press release

Share

Leading supply chain visibility company FourKites today announces the appointment of Rocky Subramanian as President, effective immediately. Widely respected as a trusted advisor to leaders executing complex digital transformation at organisations of all sizes, Subramanian will work alongside CEO Mathew Elenjickal to drive the company's strategy, growth and customer success globally.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230406005293/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

FourKites announces the appointment of Rocky Subramanian as President (Photo: Business Wire)

“As our new President, Rocky will be key to taking FourKites to the next level,” said Elenjickal. “He has a proven track record in delivering big wins for customers, building world-class teams, championing workplace diversity and culture, scaling processes and growing thriving partner ecosystems. Just as important, he passionately shares my belief that better supply chains make the world a better place. I’m honoured to welcome him to our executive team as we accelerate FourKites’ growth trajectory.”

Subramanian was most recently Executive Vice President and CRO at Ceridian (NYSE:CDAY), where he helped the company grow to over $1.2B in revenue, added some of the biggest global brands as customers, and transformed the revenue organisation. He previously served as Senior Vice President and Managing Director of one of SAP’s (NYSE:SAP) largest market units — with responsibilities spanning sales, go-to-market strategy, operations and services for the entire enterprise software portfolio — which he grew to over $1.8B. Prior to SAP, Subramanian served in various roles at Oracle/PeopleSoft (NYSE:ORCL), Renaissance and NCS Pearson. He also advises as a volunteer mentor, and supports organisations with missions focused on education accessibility and eradicating hunger.

“From the beginning, I have been inspired by FourKites’ vision. It goes far beyond visibility; FourKites is helping companies lower costs, improve customer satisfaction, enhance workplace productivity and achieve their sustainability goals. It’s helping get food, medication and critical supplies to people who need them — faster and more reliably than ever before,” said Subramanian. “Paired with the company’s world-class products, pace of innovation, rapid deployment, thriving partner ecosystem and the scale at which we can help our customers, the potential for FourKites’ global impact is limitless. I’m excited and proud to join Matt and the entire FourKites team on this mission.”

Subramanian’s appointment comes on the heels of significant momentum for FourKites. In 2022, the company realised 70% growth in new customers, with more than 1,200 of the world’s most recognised brands — including 50% of the Fortune 500 — now using FourKites to track more than 3 million shipments around the world every day. In addition to strategic investments in 2021 from industry heavyweights Qualcomm Ventures, LLC, Volvo Group Venture Capital AB and Zebra Technologies, over the past year, FourKites inked strategic partnerships with a number of industry titans to continue executing on its bold vision to provide visibility everywhere. These companies include Mitsui & Co., Ltd., Quiet Platforms, Sony, Microsoft and Narvar. The real-time supply chain visibility pioneer was also recognised for its industry leadership and ongoing innovation by Gartner, SupplyChainBrain, Blue Yonder, Builtin Chicago, Manhattan Associates and Food Shippers of America.

FourKites continues to attract top talent to its senior leadership team as it scales its global operations and reinforces its focus on customer success. In addition to Subramanian, the company recently announced the appointment of Rebecca Nerad as Vice President of Global Customer Success, and Natalie Wolf, Vice President of Customer Operations and Strategy. Nerad has over 20 years in the supply chain industry, having held senior customer success roles at e2open, i2 Technologies, JDA Software and Bristlecone, while Wolf has held senior customer experience roles at Anaplan and Celonis.

About FourKites

Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 3 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,200 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Scott Johnston
FourKites European PR Director
+31 62 147 8442
scott.johnston@fourkites.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye